Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 2048556

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 2048556

Self-monitoring Blood Glucose Devices Market Size, Share, and Growth Analysis, By Product Type (Traditional Blood Glucose Meters, Continuous Glucose Monitoring ), By Technology, By End-User, By Distribution, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Self-Monitoring Blood Glucose Devices Market size was valued at USD 14.52 Billion in 2024 and is poised to grow from USD 15.41 Billion in 2025 to USD 24.85 Billion by 2033, growing at a CAGR of 6.12% during the forecast period (2026-2033).

The global self-monitoring blood glucose devices market focuses on tools that empower individuals with diabetes to manage their glucose levels independently, mainly via portable meters, test strips, and lancing systems. The significance of this market is underscored by its role in enhancing treatment decisions and minimizing healthcare costs, acting as a pivotal element in chronic disease management and preventive care. The transition from bulky analog devices to sleek digital meters with smartphone connectivity has been revolutionary, improving accuracy and user experience. Digital innovation is reshaping the landscape by enabling automated data logging and remote monitoring, thus facilitating better adherence and enabling payers to embrace connected care. Additionally, the introduction of AI enhances predictive analytics and personalized support, further driving market growth and optimizing management strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Self-Monitoring Blood Glucose Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Self-Monitoring Blood Glucose Devices Market Segments Analysis

Global self-monitoring blood glucose devices market is segmented by product type, technology, end-user, distribution and region. Based on product type, the market is segmented into Traditional Blood Glucose Meters, Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring. Based on technology, the market is segmented into Electrochemical and Photometric. Based on end-user, the market is segmented into Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes. Based on distribution, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Self-Monitoring Blood Glucose Devices Market

The Global Self-Monitoring Blood Glucose Devices market is significantly driven by the incorporation of connectivity features and mobile applications, which greatly improve user experience. These advancements facilitate easy remote monitoring by caregivers and healthcare professionals, along with the efficient sharing of data within healthcare systems. This enhanced interoperability not only encourages patients to integrate glucose monitoring into their daily disease management routines but also strengthens clinician involvement through the availability of comprehensive longitudinal data. As a result, the simplicity of data logging and trend analysis boosts patient adherence. The growing recognition of the benefits associated with connected devices further stimulates investment from providers and payers, thereby increasing market demand for innovative and feature-rich consumer solutions.

Restraints in the Global Self-Monitoring Blood Glucose Devices Market

The Global Self-Monitoring Blood Glucose Devices market faces significant challenges due to high purchase prices and ongoing costs associated with consumables, which create affordability issues for patients. These financial barriers limit consistent use of the monitoring devices and deter potential users in budget-conscious demographics. When confronted with considerable out-of-pocket expenses, individuals may reduce the frequency of testing or postpone device replacements, diminishing the perceived value and overall market reach. Additionally, inadequate reimbursement options exacerbate these issues by transferring costs to consumers, which discourages ongoing adoption and leads healthcare providers to favor alternative management strategies that involve lower immediate expenses for patients.

Market Trends of the Global Self-Monitoring Blood Glucose Devices Market

The Global Self-Monitoring Blood Glucose Devices market is witnessing a notable trend towards connected care integration, characterized by enhanced interoperability between glucose monitoring devices and broader digital health frameworks. This evolution promotes remote monitoring and telehealth collaboration, empowering healthcare providers to tailor personalized care plans based on real-time data. The seamless exchange of information with electronic health records and mobile applications not only bolsters clinician oversight but also increases patient engagement, encouraging proactive treatment adjustments and behavioral coaching. As a result, partnerships among device manufacturers, software developers, and healthcare systems are on the rise, fostering integrated care pathways that emphasize adherence, population health management, and the advancement of value-based care models rooted in actionable glucose insights.

Product Code: SQMIG35A3433

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Self-monitoring Blood Glucose Devices Market Size by Product Type & CAGR (2026-2033)

  • Market Overview
  • Traditional Blood Glucose Meters
  • Continuous Glucose Monitoring (CGM)
  • Flash Glucose Monitoring

Global Self-monitoring Blood Glucose Devices Market Size by Technology & CAGR (2026-2033)

  • Market Overview
  • Electrochemical
  • Photometric

Global Self-monitoring Blood Glucose Devices Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

Global Self-monitoring Blood Glucose Devices Market Size by Distribution & CAGR (2026-2033)

  • Market Overview
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online

Global Self-monitoring Blood Glucose Devices Market Size by Region & CAGR (2026-2033)

  • Market Overview
  • North America
  • Europe
  • Asia-Pacific

Global Self-monitoring Blood Glucose Devices Market Size & CAGR (2026-2033)

  • North America (Product Type, Technology, End-User, Distribution, Region)
    • US
    • Canada
  • Europe (Product Type, Technology, End-User, Distribution, Region)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Technology, End-User, Distribution, Region)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Technology, End-User, Distribution, Region)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Technology, End-User, Distribution, Region)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Roche Diagnostics (Accu-Chek)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (FreeStyle)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dexcom Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic (Guardian)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ascensia Diabetes Care (Bayer)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LifeScan (Johnson & Johnson)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Senseonics Holdings
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • iHealth Labs
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Omron Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ACON Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AgaMatrix
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prodigy Diabetes Care
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arkray Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trividia Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!